3
H index
1
i10 index
35
Citations
Moritz Suppliet : Citation Profile
Universiteit van Tilburg (80% share) | RESEARCH PRODUCTION: 4 Articles 15 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
9 years (2011 - 2020). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Moritz Suppliet. | Is cited by:
| Cites to:
|
Main data
Where Moritz Suppliet has published?
| Journals with more than one article published | # docs |
|---|---|
| Journal of Health Economics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| DICE Discussion Papers / Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE) | 2 |
Recent works citing Moritz Suppliet (2024 and 2023)
| Year | Title of citing document |
|---|---|
| 2023 | Pharmaceutical regulation under market integration through parallel trade. (2023). Birg, Laura. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:56:y:2023:i:4:p:1322-1346. Full description at Econpapers || Download paper |
| 2023 | More cost?sharing, less cost? Evidence on reference price drugs. (2023). Wenzel, Tobias ; Stuhmeier, Torben ; Herr, Annika. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:2:p:413-435. Full description at Econpapers || Download paper |
Works by Moritz Suppliet:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2015 | Vergleichbarkeit internationaler Arzneimittelpreise In: Perspektiven der Wirtschaftspolitik. [Full Text][Citation analysis] | article | 1 |
| 2014 | Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG.(2014) In: DICE Ordnungspolitische Perspektiven. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | paper | |
| 2014 | The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics In: Discussion Papers of DIW Berlin. [Full Text][Citation analysis] | paper | 22 |
| 2014 | THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI?DIABETICS.(2014) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | article | |
| 2014 | The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics.(2014) In: Health, Econometrics and Data Group (HEDG) Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | paper | |
| 2014 | The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics.(2014) In: DICE Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | paper | |
| 2014 | The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics.(2014) In: VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 22 | paper | |
| 2017 | Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals In: Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2020 | Umbrella branding in pharmaceutical markets In: Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | paper | |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | paper | |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Other publications TiSEM. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | paper | |
| 2017 | Umbrella Branding in Pharmaceutical Markets.(2017) In: Other publications TiSEM. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 3 | paper | |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets In: Discussion Paper. [Full Text][Citation analysis] | paper | 6 |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Discussion Paper. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Other publications TiSEM. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2016 | Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets.(2016) In: Other publications TiSEM. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2011 | Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany.(2011) In: Health, Econometrics and Data Group (HEDG) Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2012 | Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany.(2012) In: DICE Discussion Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 4 2024. Contact: CitEc Team